| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 13433-19-7 | Glycine, L-a-aspartylglycyl-; Glycine,N-(N-L-a-aspartylglycyl)-; Succinamicacid, 3-amino-N-[[(carboxymethyl)carbamoyl]methyl]- (7CI,8CI) |  | C8H13N3O6 | 詳情 | 供應商 | |
| 10517-27-8 | Glycine, glycyl-L-a-aspartyl-; Glycine,N-(N-glycyl-L-a-aspartyl)-; Succinamic acid, 3-(2-aminoacetamido)-N-(carboxymethyl)- (7CI); Succinamicacid, 3-(2-aminoacetamido)-N-(carboxymethyl)-, L- (8CI) |  | C8H13N3O6 | 詳情 | 供應商 | |
| 149838-23-3 | 1,2,4-Butanetriol,3-[(2-nitro-1H-imidazol-1-yl)methoxy]-, (2R,3S)-rel-; 1,2,4-Butanetriol,3-[(2-nitro-1H-imidazol-1-yl)methoxy]-, (R*,S*)-; Doranidazole; PR 350; RP 343 |  | C8H13N3O6 | 詳情 | 供應商 | |
| 114522-22-4 | 1,3,5-Triazine-2,4(1H,3H)-dione,dihydro-1-b-D-ribofuranosyl- |  | C8H13N3O6 | 詳情 | 供應商 |